Arizona has approved the nation’s first clinical trial using whole mushroom psilocybin to treat post-traumatic stress disorder (PTSD) in first responders and military veterans. The federally authorized study, led by the Scottsdale Research Institute with support from Alira Health, will involve 24 participants who receive psilocybin in a controlled medical setting. Backed by the Arizona Department of Health Services, the program stems from a 2023 bill allocating $5 million for psychedelic research. Lawmakers hope the results will shape future policy and treatment access. Read more at Marijuana Moment.
The latest news on the legalization of controversial botanicals.
